Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/24 20:16 | 5/24/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 4 | S.dm | -2,185 | 51.81 | 0 | -42 | 20 | D | |||||||||||||||
5/3/24 17:50 | 5/1/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Heery Christopher | CA | O | CHIEF ME | 15 | S.dm | -13,709 | 51.07 | 0 | -268 | 30 | D | |||||||||||||||
4/18/24 16:01 | 4/16/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Ware Olivia C | CA | D | 2 | S.d | -1,156 | 62.81 | 0 | -18 | -100 | 0 | D | |||||||||||||||
4/3/24 16:44 | 4/1/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Elghandour Rami | CA | DO | SEE REMA | 5 | S.dm | -6,649 | 53.51 | 0 | -124 | 92 | D | |||||||||||||||
3/25/24 17:30 | 12/14/23 | ACLX | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | 4 | S.m | -103,299 | 51.97 | 0 | -1,988 | 2,828 | I | ||||||||||||||||
5/15/23 18:16 | 5/11/23 | ACLX | Health | BioPrd | Biological Products, (No Diag | Sr One Capital Management, LLC | PA | T | 1 | S | -45,589 | 45.01 | 0 | -1,013 | 4,487 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |